(NaturalNews) The FDA upgraded its recall of metoprolol succinate, a widely prescribed blood pressure drug, from Class III to Class II due to potential carcinog…
FDA escalates recall of blood pressure drug amid carcinogen concernsâyet another failure in Big Pharma’s toxic empire
Estimated read time
1 min read
